Intervention Arm Stage 1 vs Intervention Arm Stage II: deaths from any cause
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
Measures 6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note | Source |
|---|---|---|---|---|---|---|
| Risk in group 1 | 0.0152 | 0.0144 | 0.0161 | wilson | ClinicalTrials.gov | |
| Risk in group 2 | 0.0033 | 0.00209 | 0.00522 | wilson | ClinicalTrials.gov | |
| Risk difference, group 1 minus group 2 | 0.0119 | 0.00986 | 0.0134 | newcombe hybrid score | ClinicalTrials.gov | |
| Risk ratio, group 1 over group 2 | 4.61 | 2.9 | 7.34 | log | ClinicalTrials.gov | |
| Odds ratio, group 1 over group 2 | 4.67 | 2.93 | 7.44 | log | ClinicalTrials.gov | |
| Number needed to harm, for one more death from any cause on Intervention Arm Stage 1 than on Intervention Arm Stage II | 83.7 | 74.4 | 101 | from the risk difference interval | ClinicalTrials.gov |
Groups 2
Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code | Source |
|---|---|---|---|---|---|---|
| Group 1 | Intervention Arm Stage 1 | Annual universal community-based HIV and multi-disease testing; ART eligibility for all HIV+; ART delivery using streamlined patient-centered care~Adverse events monitored among persons initiating ART outside of National guidelines | 1,217 | 79,818 | EG000 | ClinicalTrials.gov |
| Group 2 | Intervention Arm Stage II | Baseline universal community-based HIV and multi-disease testing; ART eligibility for all HIV+; ART delivery using streamlined patient-centered care; targeted population-level PrEP~Adverse events monitored among persons initiating PrEP | 18 | 5,447 | EG001 | ClinicalTrials.gov |
Harm 2
| Field | Value | Source |
|---|---|---|
| What it counts | Total, all-cause mortality | ClinicalTrials.gov |
| Time frame | Phase I: 3 years Phase II: 3 years | ClinicalTrials.gov |
Trial 8
| Field | Value | Source |
|---|---|---|
| Title | Sustainable East Africa Research in Community Health | ClinicalTrials.gov |
| NCT number | NCT01864603 | ClinicalTrials.gov |
| Phases | NA | ClinicalTrials.gov |
| Conditions | HIV, Tuberculosis, Hypertension, Diabetes, Maternal Child Health, Cost Effectiveness | ClinicalTrials.gov |
| Interventions | Universal ART in a streamlined care model, Annual Community Health Campaigns, Targeted PrEP and Targeted testing interventions, Baseline community-based HIV and multi-disease testing | ClinicalTrials.gov |
| Lead sponsor | University of California, San Francisco | ClinicalTrials.gov |
| Results first posted | 2022-03-02 | ClinicalTrials.gov |
| Results on ClinicalTrials.gov | https://clinicaltrials.gov/study/NCT01864603?tab=results | ClinicalTrials.gov |
Source 4
| Field | Value | Source |
|---|---|---|
| Release | trial-comparisons-2026-03-23-0.1.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57 | ClinicalTrials.gov |
| AACT copy | 2026-03-23 | ClinicalTrials.gov |
| Tables read | outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet | ClinicalTrials.gov |
Release trial-comparisons-2026-03-23-0.1.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.